23410232|t|AZD1080, a novel GSK3 inhibitor, rescues synaptic plasticity deficits in rodent brain and exhibits peripheral target engagement in humans.
23410232|a|Abnormal tau phosphorylation resulting in detachment of tau from microtubules and aggregation are critical events in neuronal dysfunction, degeneration, and neurofibrillary pathology seen in Alzheimer's disease. Glycogen synthase kinase-3beta (GSK3beta) is a key target for drug discovery in the treatment of Alzheimer's disease and related tauopathies because of its potential to abnormally phosphorylate proteins and contribute to synaptic degeneration. We report the discovery of AZD1080, a potent and selective GSK3 inhibitor that demonstrates peripheral target engagement in Phase 1 clinical studies. AZD1080 inhibits tau phosphorylation in cells expressing human tau and in intact rat brain. Interestingly, subchronic but not acute administration with AZD1080 reverses MK-801-induced deficits, measured by long-term potentiation in hippocampal slices and in a cognitive test in mice, suggesting that reversal of synaptic plasticity deficits in dysfunctional systems requires longer term modifications of proteins downstream of GSK3beta signaling. The inhibitory pattern on tau phosphorylation reveals a prolonged pharmacodynamic effect predicting less frequent dosing in humans. Consistent with the preclinical data, in multiple ascending dose studies in healthy volunteers, a prolonged suppression of glycogen synthase activity was observed in blood mononuclear cells providing evidence of peripheral target engagement with a selective GSK3 inhibitor in humans.
23410232	0	7	AZD1080	Chemical	MESH:C581774
23410232	41	69	synaptic plasticity deficits	Disease	MESH:D010411
23410232	131	137	humans	Species	9606
23410232	148	151	tau	Gene	4137
23410232	195	198	tau	Gene	4137
23410232	256	276	neuronal dysfunction	Disease	MESH:D009461
23410232	330	349	Alzheimer's disease	Disease	MESH:D000544
23410232	351	381	Glycogen synthase kinase-3beta	Gene	2932
23410232	383	391	GSK3beta	Gene	2932
23410232	448	467	Alzheimer's disease	Disease	MESH:D000544
23410232	480	491	tauopathies	Disease	MESH:D024801
23410232	572	593	synaptic degeneration	Disease	MESH:D012183
23410232	622	629	AZD1080	Chemical	MESH:C581774
23410232	745	752	AZD1080	Chemical	MESH:C581774
23410232	762	765	tau	Gene	4137
23410232	802	807	human	Species	9606
23410232	808	811	tau	Gene	4137
23410232	826	829	rat	Species	10116
23410232	897	904	AZD1080	Chemical	MESH:C581774
23410232	914	920	MK-801	Chemical	MESH:D016291
23410232	1023	1027	mice	Species	10090
23410232	1057	1085	synaptic plasticity deficits	Disease	MESH:D010411
23410232	1172	1180	GSK3beta	Gene	2932
23410232	1218	1221	tau	Gene	4137
23410232	1316	1322	humans	Species	9606
23410232	1600	1606	humans	Species	9606
23410232	Association	MESH:D010411	2932
23410232	Association	MESH:D012183	2932
23410232	Negative_Correlation	MESH:C581774	MESH:D016291
23410232	Association	MESH:D000544	2932
23410232	Negative_Correlation	MESH:C581774	4137
23410232	Association	MESH:D010411	4137
23410232	Negative_Correlation	MESH:C581774	MESH:D010411
23410232	Association	MESH:D000544	4137
23410232	Association	2932	4137
23410232	Association	MESH:D009461	4137
23410232	Association	MESH:D024801	2932

